Kalbe Farma (KLBF) Eyes Growth Amid Rupiah Stability

Kalbe Farma (KLBF) Eyes Growth Amid Rupiah Stability

The easing of global trade tensions has also lifted the company’s stock valuation, which had been weighed down by its heavy reliance on imported raw materials.

user-profile

Selasa, 10 Juni 2025 | 16:24

Bisnis.com, JAKARTA - Indonesia’s largest pharmaceutical firm PT Kalbe Farma Tbk. (KLBF) is growing more optimistic as the rupiah stabilizes and its core business remains resilient.

The easing of global trade tensions has also lifted the company’s stock valuation, which had been weighed down by its heavy reliance on imported raw materials.

Bacaanmu terbatas?

Tenang, kamu hanya perlu Masuk atau Daftar dulu di sini untuk lanjut membaca Bisnis Indonesia Premium.

Nikmati Gratis Akses baca 5 artikel Bisnis Indonesia Premium bagi member baru!

atau langsung pilih paket terbaik kami:

logo

faq

berita lainnya

To Top